The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 first-in-human study of ABBV-184 monotherapy in adult patients with previously treated acute myeloid leukemia or non-small cell lung cancer.
 
Abraham Avigdor
Honoraria - Gilead Sciences; Pfizer; Takeda
Consulting or Advisory Role - Gilead Sciences; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Janssen Biotech (Inst)
 
Pierre Peterlin
Honoraria - Abbvie; Astellas Pharma; Jazz Pharmaceuticals
Research Funding - Jazz Pharmaceuticals (Inst)
 
Junichiro Yuda
No Relationships to Disclose
 
Mor Tal Moskovitz
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; MSD; Novartis; Takeda
 
Nashat Y. Gabrail
Consulting or Advisory Role - Celgene; Chemiocare
Speakers' Bureau - Janssen Oncology; Janssen Oncology; Janssen Oncology; Karyopharm Therapeutics; Taiho Pharmaceutical; Taiho Pharmaceutical; Tesaro/GSK
Research Funding - Amgen (Inst); Bayer (Inst); Chemiocare (Inst); Chemiocare (Inst); Kartos Therapeutics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Oncology Supply
 
Yakir Moshe
Honoraria - Abbvie; Astellas Pharma; Novartis
Consulting or Advisory Role - Abbvie; Astellas Pharma; Novartis
 
Bruno Quesnel
No Relationships to Disclose
 
William R Henner
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Edward B. Reilly
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Donghui Huang
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Maria Kovalenko
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Apurvasena Parikh
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Stacy Jaryno
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Rachel S Leibman
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Kevin J Freise
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Esma Saada-Bouzid
No Relationships to Disclose
 
Toshio Shimizu
Honoraria - Boehringer Ingelheim; Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Takeda
Speakers' Bureau - Boehringer Ingelheim; Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - 3D Medicines (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Chordia Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); SymBio Pharmaceuticals (Inst); Takeda/Millennium (Inst)
Travel, Accommodations, Expenses - Takeda